iShares Global Healthcare ETF (IXJ:AU) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the iShares Global Healthcare ETF stock forecast from 0 analysts, the average analyst target price for iShares Global Healthcare ETF is not available over the next 12 months. iShares Global Healthcare ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Global Healthcare ETF is Bullish , which is based on 3 positive signals and 1 negative signals. At the last closing, iShares Global Healthcare ETF’s stock price was AUD 136.62. iShares Global Healthcare ETF’s stock price has changed by -0.21% over the past week, -2.70% over the past month and +5.92% over the last year.
No recent analyst target price found for iShares Global Healthcare ETF
No recent average analyst rating found for iShares Global Healthcare ETF
Frequently Asked Questions About iShares Global Healthcare ETF (IXJ:AU) Stock
Stock Target Advisor's fundamental analysis for iShares Global Healthcare ETF's stock is Bullish .
IXJ:AU stock's dividend yield is 1.33%.
Our analysis grades IXJ:AU stock's dividend yield at F. This means that IXJ:AU stock's dividend yield is above 22% of the stocks in the Others sector in the AU exchange.
Based on this IXJ:AU may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on IXJ:AU's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IXJ:AU's stock to indicate if its overvalued.
The last closing price of IXJ:AU's stock was AUD 136.62.
The most recent market capitalization for IXJ:AU is AUD 1.35B.
Unfortunately we do not have enough analyst data on IXJ:AU's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Global Healthcare ETF's stock.
Sorry, we do not have any data on the number of employees for iShares Global Healthcare ETF.
Sorry we do not have any infomation available on iShares Global Healthcare ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IXJ:AU !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
